Speaker illustration

Doctor Christina Paitazoglou

University Heart Center, Luebeck (Germany)

Member of:

Heart Failure Association

The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study

Event: ESC Congress 2023

Topic: Multidisciplinary Interventions

Session: Complex and novel interventions for heart failure

Thumbnail

Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH

Event: Heart Failure 2023

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Heart failure with reduced ejection fraction (HFrEF) 3

Thumbnail

Comparison 8 vs. 10mm fenestration size of the atrial flow regulator in patients with heart failure with reduced and preserved ejection fraction: an analysis of the Prelieve Trial

Event: Heart Failure 2022

Topic: Diastolic Ventricular Dysfunction

Session: Heart Failure ePosters - focus on Chronic Heart Failure 5

Thumbnail

Feasibility of transcatheter procedures in patients with heart failure with reduced and preserved ejection fraction treated with the atrial flow regulator: a 3-D heart model

Event: Heart Failure 2022

Topic: Diastolic Ventricular Dysfunction

Session: Heart Failure ePosters - focus on Chronic Heart Failure 3

Thumbnail

Overcoming NOAC limitations.

Event: ESC Heart & Stroke 2022

Topic: Stroke

Session: Satellite Symposia

Thumbnail